Search Results - "ROSTY, C"

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study by Dienstmann, R., Mason, M.J., Sinicrope, F.A., Phipps, A.I., Tejpar, S., Nesbakken, A., Danielsen, S.A., Sveen, A., Buchanan, D.D., Clendenning, M., Rosty, C., Bot, B., Alberts, S.R., Milburn Jessup, J., Lothe, R.A., Delorenzi, M., Newcomb, P.A., Sargent, D., Guinney, J.

“…TNM staging alone does not accurately predict outcome in colon cancer (CC) patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent…”
Get full text

Risks of Primary Extracolonic Cancers Following Colorectal Cancer in Lynch Syndrome by KOWIN, Aung, LINDOR, Noralane M, LEGGETT, Barbara, TUCKER, Katherine M, GILES, Graham G, BUCHANAN, Daniel D, CLENDENNING, Mark, ROSTY, Christophe, ARNOLD, Julie, JOAN LEVINE, A, HAILE, Robert W, GALLINGER, Steven, PYOUNG, Joanne, LE MARCHAND, Loïc, NEWCOMB, Polly A, HOPPER, John L, JENKINS, Mark A, MACRAE, Finlay A, PYOUNG, Graeme, WILLIAMSON, Elizabeth, PARRY, Susan, GOLDBLATT, Jack, LIPTON, Lara, WINSHIP, Ingrid

“…Lynch syndrome is a highly penetrant cancer predisposition syndrome caused by germline mutations in DNA mismatch repair (MMR) genes. We estimated the risks of…”
Get full text

MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors by PETER, M, ROSTY, C, COUTURIER, J, RADVANYI, F, TESHIMA, H, SASTRE-GARAU, X

“…To determine whether integration of human papillomavirus (HPV) DNA sequences could lead to the deregulation of genes implied in oncogenesis, we analysed the…”
Get full text

Characterisation of Familial Colorectal Cancer Type X, Lynch syndrome, and non-familial colorectal cancer by Shiovitz, S, Copeland, W K, Passarelli, M N, Burnett-Hartman, A N, Grady, W M, Potter, J D, Gallinger, S, Buchanan, D D, Rosty, C, Win, A K, Jenkins, M, Thibodeau, S N, Haile, R, Baron, J A, Marchand, L L, Newcomb, P A, Lindor, N M

“…Background: Familial Colorectal Cancer Type X (FCCTX) is defined as individuals with colorectal cancer (CRC) who families meet Amsterdam Criteria-1 (AC1), but…”
Get full text

Wide metastatic spreading in infiltrating lobular carcinoma of the breast by Ferlicot, S, Vincent-Salomon, A, Médioni, J, Genin, P, Rosty, C, Sigal-Zafrani, B, Fréneaux, P, Jouve, M, Thiery, J.-P, Sastre-Garau, X

“…The aim of this study was to determine whether the metastatic potential of breast cancer could be related to phenotypic characteristics of the tumour…”
Get full text

2079 Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study by Jayasekara, H, Reece, J, Dashti, S.G, Buchanan, D, Rosty, C, Macrae, F, Boussioutas, A, Giles, G, Ahnen, D, Lowery, J, Casey, G, Haile, R, Gallinger, S, Marchand, L. Le, Newcomb, P, Lindor, N, Hopper, J, Parry, S, Jenkins, M, Win, A

Get full text

Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression by Clendenning, M, Macrae, FA, Walsh, MD, Walters, RJ, Thibodeau, SN, Gunawardena, SR, Potter, JD, Haile, RW, Gallinger, S, Hopper, JL, Jenkins, MA, Rosty, C, Young, JP, Buchanan, DD

Get full text

Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status by BRAS-GONCALVES, R. A, ROSTY, C, LAURENT-PUIG, P, SOULIE, P, DUTRILLAUX, B, POUPON, M.-F

“…Biological parameters influencing the response of human colorectal cancers (CRCs) to CPT-11, a topoisomerase 1 (top1) inhibitor, were investigated using a…”
Get full text

Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers by Hopper, J.L., Jenkins, M.A., Dowty, J.G., Dite, G.S., Apicella, C., Keogh, L., Win, A.K., Young, J.P., Buchanan, D., Walsh, M.D., Rosty, C., Baglietto, L., Severi, G., Phillips, K.A., Wong, E.M., Dobrovic, A., Waring, P., Winship, I., Ramus, S.J., Giles, G.G., Southey, M.C.

“…Genes have been identified for which germline mutations are associated with high lifetime risks of breast, colorectal and other cancers. Identification of…”
Get full text

Serrated polyposis syndrome and colonoscopic surveillance: who is it safe to follow? by Parry, S, Woodall, S, Willdridge, G, Walsh, MD, Buchanan, DD, Rosty, C, Young, JP

“…Doc number: A20…”
Get full text

Analysis of Correlation Between Mitotic Index, MIB1 Score and S-phase Fraction as Proliferation Markers in Invasive Breast Carcinoma. Methodological Aspects and Prognostic Value in a Series of 257 Cases by CALY, M, GENIN, P, ZIDANE, M, SASTRE-GARAU, X, AL GHUZLAN, A, ELIE, C, FRENEAUX, P, KLIJANIENKO, J, ROSTY, C, SIGAL-ZAFRANI, B, VINCENT-SALOMONI, A, DOUGGAZ, A

“…Background: The study was designed in order to evaluate the degree of correlation of mitotic index (MI), Ki67 (MIB1) score and S-phase fraction (SPF) as…”
Get full text

A study of cancer risks in relatives of patients with serrated polyposis by Win, AK, Walters, RJ, Buchanan, DD, Jenkins, MA, Sweet, K, McKeone, DM, Walsh, MD, Clendenning, M, Pearson, SA, Pavluk, E, Nagler, B, Hopper, JL, Walker, N, Rosty, C, Parry, S, Young, JP

“…Doc number: A21…”
Get full text

Estrogen receptors evolution in neoadjuvant aromatase inhibitor (AI) therapy for breast cancer in elderly women: stability of hormonal receptor expression during treatment by Salmon, R J, Alran, S, Malka, I, de Cremoux, P, Rosty, C, Languille, O, Campana, F, Sigal-Zafrani, B

“…In France, 20% of breast cancers occur in women over the age of 70 and 10% in women over the age of 80. As these women are not included in screening programs,…”
Get full text

The relationship between the BRAF p.V600E mutation and a family history of CRC in the early-onset CRC cases from the Australasian Colon Cancer Family Study by Buchanan, DD, Win, AK, Walters, R, Walsh, MD, Clendenning, M, Nagler, B, Pavluk, E, Pearson, SA, Rosty, C, Maskiell, J, Hopper, JL, Jenkins, MA, Young, JP

“…Doc number: A23…”
Get full text

The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study by Müller, W, Burgart, L J, Krause-Paulus, R, Thibodeau, S N, Almeida, M, Edmonston, T B, Boland, C R, Sutter, C, Jass, J R, Lindblom, A, Lubinski, J, MacDermot, K, Sanders, D S, Morreau, H, Müller, A, Oliani, C, Orntoft, T, Ponz De Leon, M, Rosty, C, Rodriguez-Bigas, M, Rüschoff, J, Ruszkiewicz, A, Sabourin, J, Salovaara, R, Möslein, G

“…Hereditary nonpolyposis colorectal cancer syndrome (HNPCC) is an autosomal dominant condition accounting for 2-5% of all colorectal carcinomas as well as a…”
Get full text

Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast by Sastre-Garau, X, Genin, P, Rousseau, A, Al Ghuzlan, A, Nicolas, A, Fréneaux, P, Rosty, C, Sigal-Zafrani, B, Couturier, J, Thiery, J-P, Magdelénat, H, Vincent-Salomon, A

“…Aims:  To determine whether cell size is related to HER‐2/neu status and/or to Akt activation in breast carcinomas. HER‐2/neu overexpression is observed in…”
Get full text

Morphologic and Immunohistochemical Analysis of Mesenteric and Retroperitoneal Mucinous Cystic Neoplasms by Van Treeck, B J, Horton, R, Graham, R P, Pai, R, Rosty, C

“…Abstract Introduction/Objective Mucinous cystic neoplasms (MCN) are neoplasms with mucinous epithelium surrounded by ovarian-type stroma, occurring in the…”
Get full text

Topoisomerase I-DNA covalent complexes in human colorectal cancer xenografts with different p53 and microsatellite instability status: relation with their sensitivity to CTP-11 by Lansiaux, A, Bras-Goncalves, R A, Rosty, C, Laurent-Puig, P, Poupon, M F, Bailly, C

“…The topoisomerase I poison CPT-11 has proved efficient for the treatment of untreated metastatic colorectal cancers (CRC) and those refractory to…”
Get more information

Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma by SATO, Norihiro, MAITRA, Anirban, FUKUSHIMA, Noriyoshi, VAN HEEK, N. Tjarda, MATSUBAYASHI, Hiroyuki, IACOBUZIO-DONAHUE, Christine A, ROSTY, Christophe, GOGGINS, Michael

“…To investigate the relationship between DNA hypomethylation and gene overexpression in pancreatic cancer, we analyzed the methylation status of a subset of 18…”
Get full text

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE) by ARGANI, Pedram, IACOBUZIO-DONAHUE, Christine, CAMERON, John L, KERN, Scott E, HRUBAN, Ralph H, BYUNGWOO RYU, ROSTY, Christophe, GOGGINS, Michael, WILENTZ, Robb E, MURUGESAN, Selva R, LEACH, Steven D, JAFFEE, Elizabeth, YEO, Charles J

“…Effective new markers of pancreatic carcinoma are urgently needed. In a previous analysis of gene expression in pancreatic adenocarcinoma using serial analysis…”
Get full text